Cargando…

P05-03. The use of immune complexes to enhance antibody responses against neutralizing epitopes on HIV envelope

Detalles Bibliográficos
Autores principales:	Hioe, CE, Visciano, M, Kumar, R, Liu, J, Tuen, M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767983/ http://dx.doi.org/10.1186/1742-4690-6-S3-P79

Ejemplares similares

Improving immunogenicity of HIV-1 envelope gp120 by glycan removal and immune complex formation
por: Kumar, R, et al.
Publicado: (2012)

Role of anti-CD4-binding site antibodies in modulating gp120-specific CD4 T cell and antibody responses
por: Visciano, ML, et al.
Publicado: (2006)

P04-43. Neutralizing antibody responses against conformational envelope epitopes in early HIV-1 infection
por: Bar, KJ, et al.
Publicado: (2009)

P05-08. Eliciting antibodies against cryptic, conserved, conformationally dependent epitopes of HIV envelope glycoprotein gp120: A strategy
por: Kelker, HC, et al.
Publicado: (2009)

P04-55 LB. Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes
por: Zolla-Pazner, S, et al.
Publicado: (2009)

P05-09. 4e10 epitope-scaffolds mimic the antibody-bound epitope conformation and block neutralization by sera from rare HIV+ individuals
por: Ban, YA, et al.
Publicado: (2009)

Effect of site-specific de-glycosylation on HIV gp120-specific CD4 T cell responses
por: Li, Hualin, et al.
Publicado: (2006)

P19-03. Molecular mechanisms for enhancing the antigenicity of the carbohydrate epitope of the broadly neutralizing anti-HIV-1 antibody 2G12
por: Fulton, Z, et al.
Publicado: (2009)

P04-09. Induction of cross-clade neutralizing antibodies with a prime/boost vaccine strategy focused on a neutralizing epitope
por: Zolla-Pazner, S, et al.
Publicado: (2009)

P07-03. HIV gp120 interaction with CD4+ T cells induces local intracellular signaling and creates an F-actin depleted zone in the virological synapse
por: Vasiliver-Shamis, G, et al.
Publicado: (2009)

P12-03. Generation of novel recombinant HIV-1 glycoproteins for expression on virus like particles
por: Tagliamonte, M, et al.
Publicado: (2009)

P12-05. Using combinatorial phage-display libraries as a source of mimetic peptides of three HIV-1 envelope epitopes
por: Palacios-Rodriguez, Y, et al.
Publicado: (2009)

P05-05. Enhanced immunogenicity of HIV-1 envelope glycoprotein trimers fused to CD40 ligand
por: Melchers, M, et al.
Publicado: (2009)

P05-10. Sequential immunization with a subtype B HIV-1 envelope quasispecies elicits broader neutralization than vaccination with a single envelope clone
por: Malherbe, DC, et al.
Publicado: (2009)

P19-11. Generation of virus-like particles expressing different HIV-1 glycoproteins for induction of broadly neutralizing antibodies
por: Visciano, M, et al.
Publicado: (2009)

Antibodies to the CD4-binding site of HIV-1 gp120 suppress gp120-specific CD4 T cell response while enhancing antibody response
por: Visciano, Maria Luisa, et al.
Publicado: (2008)

Novel vomputational methods for predicting epitopes of potent and broadly neutralizing HIV-1 antibodies
por: Evans, MC, et al.
Publicado: (2012)

P05-14 LB. Analysis of virus swarms to identify vaccine immunogens with improved exposure of epitopes recognized by broadly neutralizing antibodies
por: Berman, P, et al.
Publicado: (2009)

Effect of HIV on production of anti-viral factors by HIV-specific CD4+ T cells
por: Hioe, Catarina, et al.
Publicado: (2006)

P05-04. Neutralizing antibodies induced by immunization with liposomal gp41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes
por: Matyas, GR, et al.
Publicado: (2009)

P05-11. Yeast mannan genetics controls the molecular specificity of anti-carbohydrate antibodies cross-reactive to the HIV envelope
por: Dunlop, DC, et al.
Publicado: (2009)

P05-02. Including peptides-mimotopes of neutralizing 2F5 epitope of HIV-1 into artificial peptide TBI – vaccine candidate
por: Scherbakova, NS, et al.
Publicado: (2009)

P03-05. CD4 targeted vaccination in retroviral infection
por: Pike, R, et al.
Publicado: (2009)

Epitopes recognised by neutralising and non-neutralising anti-envelope antibodies define surface exposed regions of HTLV-1 envelope
por: Brighty, David W, et al.
Publicado: (2014)

P03-03. Protection against SIV by anti HLA class II specific antibody in the macaque model
por: Robinson, MJ, et al.
Publicado: (2009)

P13-03. Neutralizing antibody to HIV-1 Env from hyperimmune bovine colostrum as a mucosal microbicide strategy for preventing virus transmission
por: Kramski, M, et al.
Publicado: (2009)

HIV-1 p24 derived epitopes modulate KIR2DL2-binding to HLA-Cw03
por: van Teijlingen, NH, et al.
Publicado: (2012)

PA03.05. Masha taila as a preventive measure in gulpha marma injuries.
por: Dhaded, Rajani, et al.
Publicado: (2013)

P03-01. The relationship of envelope evolution to lentiviral persistence and vaccine efficacy
por: Craigo, JK, et al.
Publicado: (2009)

V5 region in the HIV-1 envelope glycoprotein determines viral sensitivity to the broadly neutralizing monoclonal antibody VRC01
por: Guo, D, et al.
Publicado: (2012)

Analysis of gp41 epitopes in model viral membranes to study HIV-1 neutralization
por: Reichart, T, et al.
Publicado: (2012)

P05-06. Masking of MPER epitopes through self-associations
por: Strong, RK, et al.
Publicado: (2009)

Construction and characterization of neutralizing antibody fragments for efficient access to V3 epitope
por: Maruta, Y
Publicado: (2012)

Alterations of HIV-1 envelope phenotype and antibody-mediated neutralization by signal peptide mutations
por: Upadhyay, Chitra, et al.
Publicado: (2018)

Construction of SHIVs expressing quaternary neutralization epitopes in Env and mimicking the neutralization phenotype of typical HIV-1 isolates
por: Theis, JF, et al.
Publicado: (2012)

P05-13. Fragments of HIV-1 gp41 derivatives presented on virus-like particles with preserved binding affinity for broadly neutralizing antibodies
por: Benen, T, et al.
Publicado: (2009)

HIV-1 envelope characteristics that coincide with the development of cross-reactive neutralizing activity in HIV-1 infected patients
por: van den Kerkhof, Tom, et al.
Publicado: (2011)

P05-03 The role of physical training in the correction of cognitive impairment in patients with type 2 diabetes
por: Matveeva, Mariia, et al.
Publicado: (2022)

P19-31. Neutralizing antibodies specific for the transmembrane envelope proteins of gammaretroviruses and of HIV-1 (2F5, 4E10): comparison of their action
por: Eschricht, M, et al.
Publicado: (2009)

P05-12. A computationally designed immunogen elicits potent anti-V3 neutralizing antibodies
por: Carrico, CT, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_clc3nd93ij34vfv93b67qj43j7